Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 145

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 145
---
 from a health
care benefit program, willfully obstructing a criminal investigation of a health care offense, and knowingly and willfully falsifying,
concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery
of or payment for health care benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need
to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Also, many states have
similar fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or,
in several states, apply regardless of the payor.

Additionally, there has
been a recent trend of increased foreign, federal, and state regulation of payments and transfers of value provided to health care
professionals or entities. The federal Physician Payments Sunshine Act imposes annual reporting requirements on certain drug,
biologics, medical supplies and device manufacturers for which payment is available under Medicare, Medicaid or CHIP for payments
and other transfers of value provided by them, directly or indirectly, to physicians (defined to include doctors, dentists,
optometrists, podiatrists and chiropractors), certain other health care providers beginning in 2022, and teaching hospitals, as well
as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, such obligations
will include payments and other transfers of value provided in the previous year to physician assistants, nurse practitioners,
clinical nurse specialists, certified nurse anesthetists, anesthesiologist assistants and certified nurse midwives. Certain foreign
countries and U.S. states also mandate implementation of commercial compliance programs, impose restrictions on device manufacturer
marketing practices and require tracking and reporting of gifts, compensation and other remuneration to health care professionals
and entities.

<div align='center'>88</div>

Penalties for violation of
any of the health care laws described above or any other governmental regulations that apply to us include, without limitation, civil,
criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs,
such as Medicare and Medicaid, injunctions, refusal to allow us to enter into government contracts, contractual damages, reputational
harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of an entity’s operations

Employees

As of the date of this prospectus,
we have three members of